• Connect
  • Bookmark Us
  • AF Twitter
  • AF YouTube
  • AF LinkedIn
  • Subscribe
  • Subscription Link
Arent Fox
  • Firm

    • History

    • Awards & Recognitions

    • Diversity

      • Overview
      • Diversity Scholarship
      • Employees on Diversity
      • LGBT Initiative
      • Women’s Leadership Development Initiative
    • Alumni

    • Pro Bono

      • Overview
      • Current Pro Bono Work
      • Community Involvement
      • Pro Bono Newsletter
      • Pro Bono Awards & Honors
      • FAQ: Pro Bono & Working at Arent Fox
    • Leadership

      • Firm Management
      • Administrative Leadership
  • Deals & Cases

  • People

  • Practices & Industries

    • Practices

      • Advertising, Promotions & Data Security
      • Government Relations
      • Antitrust & Competition Law
      • Health Care
      • Appellate
      • Insurance & Reinsurance
      • Bankruptcy & Financial Restructuring
      • Intellectual Property
      • Commercial Litigation
      • International Trade
      • Communications, Technology & Mobile
      • Labor & Employment
      • Construction
      • Municipal & Project Finance
      • Consumer Product Safety
      • OSHA
      • Corporate & Securities
      • Political Law
      • ERISA
      • Real Estate
      • Environmental
      • Tax
      • FDA Practice (Food & Drug)
      • Wealth Planning & Management
      • Finance
      • White Collar & Investigations
      • Government Contractor Services
    • Industries

      • Automotive
      • Energy Law & Policy
      • Fashion, Luxury Goods & Retail
      • Government Real Estate & Public Buildings
      • Hospitality
      • Life Sciences
      • Long Term Care & Senior Living
      • Media & Entertainment
      • Medical Devices
      • Nonprofit
      • Sports
  • Newsroom

    • Alerts

    • Events

    • Media Mentions

    • Press Releases

    • Social Media

    • Subscribe

  • Careers

    • Lawyers

    • Law Students

    • Professional Staff

  • Contact

    • Washington, DC

    • New York, NY

    • Los Angeles, CA

    Alerts

    • Newsroom Overview
      • Alerts

        Alerts by Criteria

        E.g., 1 / 21 / 2013
        E.g., 1 / 21 / 2013
      • Events
      • Media Mentions
      • Press Releases
      • Social Media
      • Subscribe

    You are here

    Home » Newsroom » Alerts

    Share

    • Printer-friendly version
    • Send by email
    • A Title
    • A Title
    • A Title
    • A
    • A
    • A

    FDA Commissioner Calls for More Compliant Food Labeling

    March 8, 2010

    On March 3, 2010, the US Food and Drug Administration (FDA) published 17 Warning Letters the agency recently issued to various food companies, including, in part, Nestle, Gorton’s, Beechnut, Ken’s Foods, and Redco, for making unauthorized health claims and nutrient content claims on the labeling of several of their various food products. The publication of these enforcement actions is intended to underscore FDA’s continued commitment to food labeling compliance, particularly with respect to nutritional claims.

    On March 3rd, FDA Commissioner Margaret Hamburg also published an open letter to the food industry, which stated that “access to reliable information about the calorie and nutrient content of food is important, given the prevalence of obesity and dietary related diseases in the US.” Noting that the use of nutritional symbols and nutritional claims on the principal display panel of food products (aka, “front-of–pack” labeling) had grown rapidly in recent years, Commissioner Hamburg announced that FDA plans to issue draft guidance in the near future relating to front-of-pack calorie and nutrient content labeling. FDA also plans to issue a second draft guidance that would recommend nutritional criteria for foods that make “dietary guidance” statements (e.g., “eat two cups of fruit a day for good health”). A link to Commissioner Hamburg’s letter to industry may be read by clicking http://www.fda.gov/Food/LabelingNutrition/ucm202733.htm

    Several of the common violations FDA cited in the 17 Warning Letters published yesterday include the following:

    • The use of a nutrient content claim on the front panel that a product contains no “trans fats”, is misleading when the claim is not accompanied by a statement (eg., “See nutrition information for fat content”) disclosing that the product contains high levels of either “saturated fat,” “total fat,” or “sodium.”

    • Misleading “healthy” claims that appear on foods that do not meet the well-established definition for use of that term.

    • Nutrient content claims, such as “no added refined sugar” and “added vitamins and minerals”, appearing on products intended for children under 2 years of age. Such claims are not permitted because appropriate dietary levels have not been established for children in this age range.

    • The product makes claims such as “full of nutritious antioxidants” but does not meet the requirements for making the claim – (i) an RDI must be established for each nutrient that is the subject of the claim; and (ii) the level of each subject nutrient in the product must be sufficient to justify the claim (e.g., to make the claim “high in antioxidant vitamin c,” the product must contain 20 percent or more of the RDI for vitamin c).

    In light of Commissioner Hamburg’s continuing interest in promoting nutritional labeling compliance, we expect FDA compliance officers will continue to closely monitor food labeling and issue Warning Letters to companies when food labeling violations are uncovered.

    For additional information, please contact Georgia Ravitz, James Ravitz, or James Hartten.

    Or any of the other attorneys of the Arent Fox Food and Drug Practice, including Brian Waldman, Stanely Abramson, Joanne Hawana, Rachel Lattimore, or Wayne Matelski.

    Related People

    • Stanley H. Abramson
    • James H. Hartten*
    • Joanne S. Hawana
    • Wayne H. Matelski
    • Georgia Ravitz
    • James R. Ravitz
    • Brian P. Waldman

    Related Practices

    Consumer Product Safety
    FDA Practice (Food & Drug)

    Related Industries

    Life Sciences
    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Contact

    Footer Main

    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Subscribe
    • Alumni
    • Diversity
    • Legal Notice
    • Privacy Policy
    • Social Media Disclaimer
    • Nondiscrimination
    • Site Map
    • Client/Staff Login

    Offices

    • Washington, DC
      1717 K Street, NW
      Washington, DC 20036
      Tel: 202.857.6000
    • New York, NY
      1675 Broadway
      New York, New York 10019
      Tel: 212.484.3900
    • Los Angeles, CA
      555 West Fifth Street, 48th Floor
      Los Angeles, California 90013
      Tel: 213.629.7400
    • © Copyright 2013 Arent Fox LLP. All Rights Reserved.

      Legal Disclaimer
      Contents may contain attorney advertising under the laws of some states. Prior results do not guarantee a similar outcome.